Eli Lilly xStock is projected to rise to $1,365.41 by 2027, a +19% move from its current price of $1,147.79. LLYX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 12/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 6/6/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jun 7 | $1,121.36 | $1,149.58 | $1,178.51 | +0.16% |
| Jun 8 | $1,111.60 | $1,151.37 | $1,192.57 | +0.31% |
| Jun 9 | $1,104.57 | $1,153.17 | $1,203.90 | +0.47% |
| Jun 10 | $1,098.95 | $1,154.97 | $1,213.83 | +0.63% |
| Jun 11 | $1,094.23 | $1,156.77 | $1,222.88 | +0.78% |
| Jun 12 | $1,090.13 | $1,158.57 | $1,231.30 | +0.94% |
| Jun 13 | $1,086.52 | $1,160.38 | $1,239.25 | +1.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1,086.52 | $1,160.38 | $1,239.25 | +1.10% |
| Week 2 | $1,068.92 | $1,173.10 | $1,287.44 | +2.21% |
| Week 3 | $1,058.28 | $1,185.96 | $1,329.05 | +3.33% |
| Week 4 | $1,051.20 | $1,198.97 | $1,367.51 | +4.46% |
| Week 5 | $1,046.36 | $1,212.12 | $1,404.14 | +5.60% |
| Week 6 | $1,043.09 | $1,225.41 | $1,439.60 | +6.76% |
| Week 7 | $1,041.00 | $1,238.85 | $1,474.30 | +7.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Eli Lilly xStock (LLYX) is a tokenized stock within the xStocks ecosystem. xStocks are tokenized stocks backed 1:1 by the underlying assets, composable with DeFi protocols, compliant with EU regulations, accessible to non-US users, and provide a legal claim to the value of the stock. xStocks enable easy access to 57 US Stocks and ETFs to regular users through top centralized and decentralized exchanges, and can be integrated with other DeFi protocols like any other token.
Eli Lilly xStock (LLYX) is currently priced at $1,065.14 and ranks 3618 by market capitalization, with a market cap of $492.12K. The asset is a tokenized stock designed to provide a 1:1 claim to the underlying Eli Lilly share, accessible through both centralized and decentralized venues as part of the 57 US Stocks and ETFs available via xStocks.
All-time high for LLYX is $1,153.38 and all-time low is $624.79. The 30-day range spans from $942.98 to $1,203.13, reflecting recent volatility within a broad trading envelope. The near-term outlook sits within a larger forecast that anticipates upside over multiple years, set against current price levels and historical extremes.
A major floor 25.4% below — a decisive break under it would weaken the trend.
The nearest floor, 17.2% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 11.4% above — clearing it would confirm fresh momentum.
Key LLYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LLYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1,098.00 | Buy | $1,111.88 | Buy |
| MA 10 | $1,102.72 | Buy | $1,097.50 | Buy |
| MA 20 | $1,070.31 | Buy | $1,072.50 | Buy |
| MA 50 | $994.92 | Buy | $1,024.15 | Buy |
| MA 100 | $976.87 | Buy | $1,001.26 | Buy |
| MA 200 | $1,015.23 | Buy | $976.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.31 | Neutral |
| Stoch RSI (14) | 59.16 | Neutral |
| CCI (20) | 147.51 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 1.13 | Buy |
| ROC (12) | 9.41 | Buy |
| Bollinger %B (20,2) | 0.95 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.48 | Buy |
| Awesome (5,34) | 62.53 | Buy |
| Ultimate (7,14,28) | 63.59 | Neutral |
| Momentum (10) | 58.45 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 1104.04 | Buy |
| ADX (14) | 25.00 | Buy |
| ATR (14) | 20.16 | Info |
The 30-day range is $942.98 to $1,203.13. The RSI(14) is 50, with the SMA50 at $985.66 and the SMA200 at $1,014.07. Support is at $950.86 and resistance at $1,143.64, framing a bullish tilt in the near term while volatility remains a meaningful factor (annualized volatility around 40%).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $855.88 | $1,147.79 | $1,724.66 | 0% | Neutral | |
| $1,079.28 | $1,365.41 | $1,832.19 | +19% | Neutral | |
| $1,473.97 | $1,918.77 | $2,672.33 | +67% | Bullish | |
| $3,440.95 | $4,587.74 | $6,579.81 | +300% | Bullish | |
| $2,966.51 | $4,040.00 | $5,939.62 | +252% | Bullish | |
| $3,543.86 | $4,920.75 | $7,393.09 | +329% | Bullish | |
| $7,253.69 | $10,255.90 | $15,711.57 | +794% | Bullish | |
| $7,331.84 | $10,544.28 | $16,440.94 | +819% | Bullish | |
| $8,153.15 | $11,916.84 | $18,885.24 | +938% | Bullish | |
| $9,654.69 | $14,332.19 | $23,058.05 | +11.5x | Bullish | |
| $31,812.42 | $50,680.94 | $86,858.48 | +43.2x | Bullish | |
| $81,517.55 | $146,779.49 | $275,819.88 | +126.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| June 2026 | $855.88 | $1,147.79 | $1,370.94 | +0.00% |
| July 2026 | $1,039.63 | $1,230.09 | $1,496.73 | +7.17% |
| August 2026 | $1,110.08 | $1,323.04 | $1,628.35 | +7.56% |
| September 2026 | $1,054.60 | $1,264.38 | $1,570.45 | -4.43% |
| October 2026 | $1,009.73 | $1,217.12 | $1,524.22 | -3.74% |
| November 2026 | $1,085.83 | $1,315.04 | $1,658.60 | +8.05% |
| December 2026 | $1,116.52 | $1,358.30 | $1,724.66 | +3.29% |
Click any year to see its month-by-month LLYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The LLYX price prediction for 2026 points to an average of $1,147.79 (low $855.88, high $1,724.66) — a potential gain of 0% on today's $1,147.79. Price action looks broadly range-bound.
In 2027, LLYX is projected to trade between $1,079.28 and $1,832.19, averaging $1,365.41 — a potential gain of +19% from today's $1,147.79. That is up +19% on the projected 2026 average. A consolidation phase looks the most probable path here.
Eli Lilly xStock's 2028 outlook centres on $1,918.77, within a $1,473.97 to $2,672.33 range. That is up +41% on the projected 2027 average. That marks a +67% change versus current levels. Momentum favours further upside here.
By 2029, LLYX could reach as high as $6,579.81, with a base case around $4,587.74 and support toward $3,440.95 — roughly +300% from $1,147.79. Buyers look set to stay in control over this stretch.
Expect LLYX to range from $2,966.51 to $5,939.62 through 2030. The $4,040.00 average target implies a +252% move from current prices. That is -12% versus the projected 2029 average. Momentum favours further upside here.
The LLYX price prediction for 2031 points to an average of $4,920.75 (low $3,543.86, high $7,393.09) — a potential gain of +329% on today's $1,147.79. Buyers look set to stay in control over this stretch.
In 2032, LLYX is projected to trade between $7,253.69 and $15,711.57, averaging $10,255.90 — a potential gain of +794% from today's $1,147.79. That is up +108% on the projected 2031 average. Momentum favours further upside here.
Eli Lilly xStock's 2033 outlook centres on $10,544.28, within a $7,331.84 to $16,440.94 range. That is up +3% on the projected 2032 average. That marks a +819% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, LLYX could reach as high as $18,885.24, with a base case around $11,916.84 and support toward $8,153.15 — roughly +938% from $1,147.79. Momentum favours further upside here.
Expect LLYX to range from $9,654.69 to $23,058.05 through 2035. The $14,332.19 average target implies a +11.5x move from current prices. That is up +20% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The LLYX price prediction for 2040 points to an average of $50,680.94 (low $31,812.42, high $86,858.48) — a potential gain of +43.2x on today's $1,147.79. Momentum favours further upside here.
In 2050, LLYX is projected to trade between $81,517.55 and $275,819.88, averaging $146,779.49 — a potential gain of +126.9x from today's $1,147.79. That is up +190% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in LLYX today (≈ 0.87124 LLYX) could be worth
$127,880.09
+$126,880.09 (+12688%) by 2050 · US Dollar
Based on the average projected LLYX price of $146,779.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LLYXwould be worth at today's price.
$1,000 invested in LLYX on Jul 29, 2025 (≈ 1.311162 LLYX) would be worth
$1,504.94
+$504.94 (+50.5%) today · 1.50× · US Dollar
Based on a LLYX entry price of $762.68 vs. today's $1,147.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1,112.68 | $1,031.55 | +3.2% |
| 1 month ago | $989.49 | $1,159.98 | +16.0% |
| 3 months ago | $1,049.96 | $1,093.17 | +9.3% |
| 6 months ago | $1,006.86 | $1,139.97 | +14.0% |
| All time ago | $762.68 | $1,504.94 | +50.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LLYX forecast.
Our base-case forecast reaches $2,300.00 around 2029.
Implied market cap at $2,300.00: $1.07M
The year-by-year forecast shows meaningful upside across the longer horizon. For 2026, the min, avg, and max are $855.88, $1,065.14, and $1,578.17 respectively, with a 0 ROI and neutral sentiment. By 2027 the avg rises to $1,286.81 (ROI 20.8) and 2028 to $1,747.00 (ROI 64), with bullish sentiment continuing.
2029 features a strong upturn with min $2,955.36, avg $3,878.11, max $5,455.42 (ROI 264.1). 2030 shows min $2,644.60, avg $3,535.97, max $5,088.45 (ROI 232). The forecast extends to 2031 ($4,280.97 avg), 2032 ($8,156.66 avg, ROI 665.8), 2033 ($8,561.33 avg, ROI 703.8), 2034 ($9,747.22 avg, ROI 815.1), 2035 ($11,338.02 avg, ROI 964.5), then dramatically higher in later years: 2040 ($37,256.27 avg), ROI 3397.8, and 2050 ($101,341.79 avg), ROI 9414.4, all with bullish sentiment.
These figures illustrate a forecasted path of substantial appreciation with very wide ranges, underscoring the estimates nature of the outlook and the associated risks.
Tap a question to reveal the answer.
Min $855.88, Avg $1,065.14, Max $1,578.17; ROI 0; Sentiment NEUTRAL.
Forecasts show bullish sentiment beginning in 2027 with rising averages: 2027 Avg $1,286.81 (ROI 20.8), 2028 Avg $1,747.00 (ROI 64), 2029 Avg $3,878.11 (ROI 264.1).
Yes. The 2029 forecast has a min of $2,955.36 and a max of $5,455.42, with an average of $3,878.11.
2030 forecast: Min $2,644.60, Avg $3,535.97, Max $5,088.45; ROI 232; Sentiment BULLISH.
2050 forecast: Min $59,498.57, Avg $101,341.79, Max $183,085.13; ROI 9414.4; Sentiment BULLISH.
Eli Lilly xStock Community Discussion
0Share your Eli Lilly xStock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.